Whitepaper

The State of Animal Health R&D 2026

We surveyed more than 100 animal health R&D professionals across 50 organizations to build a first-of-its-kind benchmark on how studies really run, and where they are headed.

What's inside

  • How confident R&D teams feel about the industry compared with last year
  • Which tools teams use to run studies, and where the capability gaps are
  • What slows studies down most, and how long evidence delays last
  • Where AI is being used in animal health R&D, and what holds it back

Free to download. Built from the answers of your peers, competitors, and colleagues.

Get your free copy

A note from our CEO

The risk that gets the least attention

Safety and regulatory risk dominate the conversation in product development. This report looks at the third kind, operational risk, through the eyes of 107 professionals at more than 50 organizations who shared how their studies actually run.

Tommy Jackson, CEO of Prelude

“It would be a shame to develop a product that is safe, effective, and backed by high-quality data, only to see approval delayed or denied because of how the study was conducted.”

Tommy Jackson

CEO, Prelude